Jobs
View more job listings or post a job
InnoAlliance Scientist/Sr Scientist of Bioanalysis & Biomarkers
Bioduro-Sundia Associate Director/Director in Laboratory Animal and Exploratory Toxicology
Variant Bio (Senior) Scientist - DMPK
Alturas Analytics Scientist 1
University of California, Davis TOXICOLOGY ANALYTICAL CHEMIST (STAFF RESEARCH ASSOCIATE 3)
University of California, Davis CALIFORNIA ANIMAL HEALTH AND FOOD SAFETY LABORATORY - TOXICOLOGY LAB RESEARCH SUPERVISOR/GROUP LEADER
Eli Lilly and Company R-39973 Scientific Director ADME - Novel Modalities (Open)
FibroGen Director DMPK
Post a job

Symposium

[In Person] Antibody Engineering for ADCs


Speakers: Bernhard Geierstanger, PhD, Co-founder and Chief Technology Officer, Firefly Bio
Organizers: PBSS Vancouver
Date: 2024-09-11
Time: 10:00-12:30 Pacific Time
Registration fee: Attendees, CDN$10; Vendors: CDN$350; Major Sponsor: CDN$1500
Location: The Floral Hall @ VanDusen Gardens, Vancouver (Oak St at 37th Ave; parking is free)
Major Sponsor: (1)Abzena
Vendor show vendors registered to date: (7)Altasciences; Curia Global; Frontage Laboratories; Labcorp; Sciex; Unchained Labs; WuXi Apptec
Registration: http://www.PBSS.org
Registration deadline:2024-09-01  (it will close sooner if the seating cap is reached)


About the Speakers

Bernhard Geierstanger is CTO and co-founder of FireflyBio, a bay area ADC startup. He is an expert in protein engineering, ADCs and biotherapeutics. Before FireflyBio, he worked at Merck (MRL) and the Genomics Institute of the Novartis Research Foundation (GNF) leading teams that develop innovative biotherapeutics. Several of these have advanced to clinical trials. He has also pioneered novel methods for protein modification, site-specific conjugation, and the use of immune stimulating ADC payloads.

Bernhard holds a Ph.D. in Biophysics from UC Berkeley and was a postdoctoral fellow at Stanford University. He has authored >60 publications and is an inventor on >30 patents and patent applications.


2024-10-22, [In-Person] Translational Pharmacology Models in Drug Development: Fundamentals, Applications, and Case Studies Related to Oncology, Metabolic Diseases, CNS, and Immunology
©Pharmaceutical & BioScience Society, International; Last Modified: 10/3/2024; Admin Logon
Ads (in random order)
Submit a Text Ad
($250 for 2 months)

PharmaResources Top-tier small molecule CRO/CDMO offering comprehensive supports from Medicinal Chemistry, DMPK, and CMC to GMP manufacturing for commercialization.
Alturas Analytics, Inc. Expert Regulated & Non-Regulated LC-MS, GC-MS bioanalytical & PK/TK analysis of small & large molecules in any matrix. Discovery through phase IV.
Allucent Bringing innovation to Biotech w/ClinPharm Modeling & Simulation services to inform dose, design, modeling + development strategies.
Aroga Biosciences Aroga Biosciences is an award-winning CRO specializing in scientific writing for nonclinical reports, INDs, CMC, and clinical documents.
Submit a Text Ad